C-X-C Chemokine Receptor Type 4 Market Share, Symptoms, 2016 C-X-C Chemokine Receptor Type 4 Market Кликнуть для чтения
  • Комментарии

C-X-C Chemokine Receptor Type 4 Market Share, Symptoms, 2016

C-X-C Chemokine Receptor Type 4 Market

Опубликовано в "Здоровье и фитнес, Здоровье и фитнес", язык - English. 4 страниц.
The report provides comprehensive information on the C-X-C Chemokine Receptor Type 4 (Fusin or Leukocyte-Derived Seven Transmembrane Domain Receptor or Lipopolysaccharide-Associated Protein 3 or Stromal Cell-Derived Factor 1 Receptor or CD184 or CXCR4), targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. Read More @ http://www.radiantinsights.com/research/c-x-c-chemokine-receptor-type-4 Еще
Бесплатно